WeVote

Bill

Bill

HB 822

AN ACT relating to coverage for colorectal cancer examinations and laboratory tests and declaring an emergency.

2026 Regular Session Introduced by Deanna Gordon

Kentucky bill mandates health insurance coverage of colorectal cancer screenings and lab tests to improve early detection access and reduce mortality rates.

to Banking & Insurance (H)
0
WeVote Research Nonpartisan
Bill Summary · HB 822

Legislative bill overview

HB 822 would require health insurance coverage for colorectal cancer screening examinations and related laboratory tests in Kentucky. The bill appears to mandate that insurers cover these preventive services, likely without cost-sharing requirements like copays or deductibles. An emergency clause suggests the sponsors want expedited passage.

Why is this important

Colorectal cancer is the second leading cause of cancer death in the U.S., but screening rates remain below optimal levels, partly due to cost barriers. Removing financial obstacles to screening could increase early detection rates, when treatment is most effective and less costly. This directly affects Kentucky residents' access to preventive care and potentially reduces long-term healthcare costs through earlier intervention.

Potential points of contention

  • Insurance cost impact: Insurers and employer-sponsored plans may argue that mandated coverage without cost-sharing increases premiums for all enrollees, even those at lower risk
  • Scope ambiguity: The bill's language regarding which specific tests qualify (colonoscopy, FIT, CT colonography, etc.) and screening intervals could create implementation disputes
  • Emergency designation: The expedited timeline may limit legislative debate and amendment opportunities, raising concerns about insufficient vetting of fiscal and practical implications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.